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ABSTRACT 
 
Many biochemical processes involve binding between carbohydrates and 
biomolecules on the surface of cells. These may involve multivalent interactions that can 
considerably alter the binding specificity and avidity of biomolecules. A novel nanocube 
sensor has been developed to elucidate the cooperativity in binding of biomolecules to 
carbohydrates. A fluidic supported lipid bilayer coated on the nanocube sensor allows 
this system to mimic a cell membrane in vitro. Cholera toxin B (CTB) subunit has been 
taken as a model system and its binding with several gangliosides has been demonstrated 
using this sensor.  The amount of CTB bound to the lipid bilayer is then quantified by 
observing the shifts in the quadrupolar localized surface plasmon resonance peak using a 
standard laboratory spectrometer. 
The ultimate objective of this research is to provide a diagnostic tool to quickly 
identify diseases. This inexpensive, label free, high throughput technology allows the 
testing of several conditions simultaneously. This helps researchers understand the 
mechanism of binding and quantify the binding of biomolecules, which may enable the 
development of treatments for diseases involving membrane recruitment. 
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NOMENCLATURE 
 
CTB Cholera Toxin B subunit 
GM1 Monosialoganglioside GM1 
GM2 Monosialoganglioside GM2 
fGM1 Fucosylated monosialoganglioside GM1 
LSPR Localized surface plasmon resonance 
GD1b Disialoganglioside GD1b  
aGM1 Asialoganglioside GM1 
GM3 Monosialoganglioside GM3 
LSPR                          Localized surface plasmon resonance 
MINLP Mixed integer nonlinear programming 
GM1os Monosialoganglisoside GM1 oligosaccharide  
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1. INTRODUCTION  
 
 Cholera is a virulent disease caused by consuming food or water contaminated 
with the bacterium known as Vibrio cholerae. [1] It causes an acute diarrheal infection 
and has caused several pandemics over many decades primarily due to lack of access to 
clean drinking water. Cholera not only poses a public health hazard but also lacks 
effective treatment. [2] 
Other diseases which have recently affected a large population include Ebola and 
Zika virus epidemics, and treatment is largely symptomatic in these cases.[3-5] As these 
diseases resemble several others, like malaria and dengue respectively, it is often too late 
before any effective treatment may be administered. A common theme which may be 
observed among these diseases is that lives were lost primarily due to lack of access to 
proper diagnostic tools, lack of appropriate treatment methods and unavailability of 
qualified medical personnel. Clearly, there is a need to have an effective and inexpensive 
diagnostic tool, and a means to identify potential treatments in diseases involving 
membrane recruitment. 
Many diseases involve biochemical processes that include binding between 
carbohydrates and biomolecules on the surface of cells. Glycan bound subunits may 
interact with neighboring binding domains thereby influencing the avidity with which it 
binds. Therefore, such cooperative binding can play a significant role in facilitating 
biochemical processes which in turn plays significant role in the propagation of diseases. 
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 A nanocube sensor has been developed to quantify the binding between 
carbohydrates and biomolecules. A model system of cholera toxin has been studied here; 
to illustrate the use of this technology in understanding the role of cooperativity in 
binding of cholera toxin B (CTB) subunit with several gangliosides.  
3 
2. BACKGROUND
*
2.1 Advantages of the nanocube system 
Glycoarrays are currently used for glycan recognition and have glycans 
immobilized on a surface. [6] [7] Fluorescent labeling or immunostaining techniques can 
then be used to observe the amount of bound analyte. [8] However, this technology has 
many limitations. It is difficult to have multivalent binding in conventional glycoarrays, 
since the spacing and orientation of glycans cannot be properly controlled. These 
glycoarrays are typically used to study isolated glycans rather than several glycan 
structures and therefore it is difficult to obtain information on the binding cooperativities 
among glycans. Additionally, these glycoarrays offer little flexibility or ease of access 
and require special instrumentation to fabricate. One solution to this issue is to use 
fluidic bilayers where glycans may freely diffuse enabling them to organize themselves 
such that multivalent binding may be observed. [9, 10] However, this method also 
requires special equipment and the bilayers formed may not be stable for a long time. 
The nanocube sensor overcomes these problems and allows not only a fluidic bilayer but 
also label free detection and simple measurement requiring just a microplate reader. 
*Parts of this section have been reprinted with permission from “Binding Cooperativity Matters: A GM1-
Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” 
by Nolan C. Worstell, Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), 
Copyright [2016] by Worstell et al. [11] 
_______________________________
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2.2 The nano-cube sensor 
2.2.1 Silver nanocube synthesis 
Silver nanocube sensors are synthesized using a previously established protocol 
known as the polyol method. [12] [13] This method involves the reduction of silver 
nitrate with pentane diol near its reflux temperature in the presence of 
poly(vinylpyrrolidone) as an agent to control the shape of the structure. The silver 
nanocubes formed are highly monodisperse and have an edge length of ~100 nm which 
can be confirmed by SEM. (Figure 1) 
Figure 1. SEM image of a batch of silver nanocubes 
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2.2.1.1 Silver nanocube synthesis procedure 
The nanocube synthesis procedure was taken from Tao et al. [12] . The procedure 
was based on the polyol method and described in brief as follows. First, 0.2 g of PVP 
was dissolved into 10 mL of PD. Next, 0.2 g of AgNO3 was dissolved into 10 mL of PD 
with 30 μL of a 0.082 g/mL CuCl2 in PD solution. Then, 20 mL of PD was heated in a 
190°C silicon oil bath. After the PD was heated sufficiently, 500 μL of AgNO3 solution 
and 500 μL of the PVP solution were added sequentially every minute. This was 
continued until all 10 mL of both the AgNO3 and PVP solutions were added. When 
finished, the nanocubes were washed with 200 proof ethanol using a centrifuge. 
 
2.2.2 Silica coating on the silver nanocube 
 A modified Stöber process is used to coat the nanocube with a thin layer of 
silica. [11] The silver nanocubes are first suspended in a 2-propanol. The solution is then 
mixed with water, tetraethyl ortho-silicate (TEOS) and ammonia. TEOS gets hydrolyzed 
to form silica which forms a thin layer on the surface of the silver nanocubes. Ammonia 
acts as a catalyst for the reaction. The thickness of the silica layer can be estimated using 
a TEM image of the nanocubes. (Figure 2) This silica coating allows the surface to be 
hydrophilic. This allows the silica coated cubes (Ag@SiO2) to easily suspend in water 
and therefore, study binding in aqueous media. 
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Figure 2. TEM image of a single cube from batch of silica coated cubes 
 
 
 
 
2.2.2.1 Silica coating procedure 
Our silica coating procedure was adapted from Wu et al. with few alterations and 
presented with alterations as follows. [13]  To improve silica shell quality in the scaled-
up synthesis batch, the silica coating reaction was conducted in 2-propanol, instead of 
ethanol. 20 mL of stock silver nanocube stored in ethanol was first transferred into 2-
propanol. Then, the silver nanocube solution was suspended into 55 mL of 2-propanol 
and mixed with 22.1 mL of water, 6.80 mL of TEOS, and 3.4 mL of 0.84% ammonium 
hydroxide solution. Next, the solution was stirred at room temperature for 80 minutes. 
After the reaction finished, 50 mL of ethanol were added to quench the reaction. The 
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resultant particles were washed with Milli-Q
®
 water a few times, and stored in Milli-
Q
®
 water for future use. 
 
2.2.3 Extinction spectra of the silica coated nanocubes 
The extinction (both absorption and scattering) spectrum of the silica-coated 
cubes (Ag@SiO2) is observed using a standard UV-vis spectrophotometer. This 
spectrum includes the sharp quadrupolar localized surface plasmon resonance (LSPR) 
peak exhibited by the Ag@SiO2 cubes. Silver nanocubes can have several spectral peaks 
and may have a substantial contribution from scattering as well. It should be noted that 
the field enhancement from the quadrupolar mode is higher than the dipole mode. [14] 
 
2.2.4 Localized surface plasmon resonance  
LSPR is the optical phenomenon generated when light interacts with conductive 
nanoparticles smaller than their wavelength. [15] It occurs when the frequency of 
movement of free electrons is nearly the same as the incident light. [16] Electric field of 
light collectively excites electrons in the conduction band resulting in coherent localized 
plasmon oscillations. [17] At a specific frequency of light, this collective oscillation 
results in a strong extinction of light. [18] This phenomenon is called localized surface 
plasmon resonance and the frequency at which this occurs is called as resonant 
frequency. This resonant frequency depends on several factors including the size, 
composition, geometry of the nanoparticle and the dielectric properties of the medium. 
[17] 
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2.2.5 Why silica coated silver nanocubes? 
Silver is chosen for developing the sensor because it is a d-block element that 
exhibits localized surface plasmon resonance in the visible region of light. Silver also 
has the sharpest band energy gap and can exhibit better sensitivity than other metal 
nanoparticles. [19] Another crucial reason for using silver is because there is a well-
established protocol to prepare a mono-disperse batch of nanocubes. [13] There have 
been semiconductors developed, which exhibit LSPR in the visible wavelength and may 
offer even sharper band energy gaps. [20] However, a protocol to prepare a highly 
mono-disperse batch of nanocubes has not yet been developed. 
A cubic shape allows a uniform coating of the nanocubes and the corners of the 
cubes allow enhancement of the LSPR peak. [13]  A highly irregular shape will allow 
enhancement, but a uniform supported lipid bilayer may not be coated. On the other 
hand, a spherical shape may allow uniform coating but will offer little field 
enhancement. Therefore, a cubic shape is optimally chosen. 
Silica coating allows the surface to be hydrophilic in nature. This enables us to 
study protein binding in aqueous solutions and can also potentially increase the shelf life 
of silver nanocubes. 
  
2.2.6 Supported lipid bilayer on the silica coated silver nanocubes 
Supported lipid bilayers are coated on the surface of Ag@SiO2. [11] Lipids of the 
required composition initially stored in chloroform or a mixture of chloroform, methanol 
and water are dried using a rotary evaporator. They are hydrated by adding water to get a 
9 
specific concentration of lipids. To attain small unilamellar vesicles (SUVs), the lipids 
are then extruded through filters or subjected to tip sonication. The SUVs are then coated 
on the silver nanocube using a modified vesicle fusion technique. It involves adding the 
cubes sequentially to the lipids while sonicating the solution in a bath sonicator. This 
ensures that the concentration of SUVs is always high and a lower amount of vesicles 
are needed as compared to the conventional vesicle fusion method. This fluidic 
supported lipid bilayer mimics the cell membrane and allows the lipids to have 
movements similar to those observed in the cell membrane. It can be observed on a cryo-
TEM. (Figure 3) 
Figure 3. Cryo-TEM image showing the lipid bilayer coated on Ag@SiO2 cubes [11] 
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2.2.6.1 Supported Bilayer Preparation 
Small unilamellar vesicles (SUVs) were prepared as follows. The desired 
composition of lipids in chloroform was mixed and then dried using a rotary evaporator 
(Heidolph Hei-VAP Value
®
). Then, the dried lipids were rehydrated with Milli-Q
®
 water 
and extruded through 100 nm polycarbonate filters (Whatman) using a Mini-extruder 
(Avanti Polar Lipids) or tip sonicated (Qsonica) to achieve an extruded lipid 
concentration of 3 mg/mL. Supported lipid bilayers were formed by a modified vesicle-
fusion technique. In this technique, Ag@SiO2 nanocubes were sequentially added into a 
SUV solution with a high SUV concentration in the initial coating solution. Briefly, 10 
μL of nanocube solution and 30 μL of 2X TBS buffer were added to 20 μL of 
concentrated SUV solution (3 mg/mL) followed by 10 seconds of sonication in a bath 
sonicator (Branson). Then, 10 μL of nanocube solution and 10 μL of 2X TBS buffer 
were added followed by 10 seconds of sonication. This process was repeated until all of 
the nanocube solution had been added. After coating the supported bilayer, TBS buffer 
was added to the solution to reach the desired concentration of salt (1X TBS), SUV’s, 
and nanocubes in the final solution. 
 
2.2.7 Protein binding on the lipid bilayer coated Ag@SiO2 
Proteins can then be added to this lipid coated Ag@SiO2 cubes. The amount of 
protein bound can be quantified by observing shifts in the location of the localized 
surface plasmon resonance (LSPR) peak in the extinction spectra of the lipid coated 
Ag@SiO2 cubes. As proteins are organic molecules, the more they bind, the more they 
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alter the dielectric environment around the cubes. Since the LSPR peak is extremely 
sensitive to the dielectric environment, even small changes in the dielectric environment 
may be easily observed. [17] 
Numerous biochemical processes begin through membrane recruitment and this 
tool can play a significant role in quantifying the binding of biomolecules and therefore 
serve as an effective diagnostic tool. 
 
2.2.7.1 Protein binding measurement 
Bilayer coated nanocubes were incubated with the desired protein concentration 
in a 384 well plate for 1.5 hours. Blank solutions were prepared for each CTB 
concentration by mixing buffer, SUVs, and CTB corresponding to that composition. 
Next, the 384 well plate was placed in a vacuum chamber at 40 cm Hg of vacuum for 15 
minutes to remove air bubbles before collecting extinction spectra with a UV/Vis 
microplate spectrophotometer equipped with a CCD (FLUOstar Omega
®
, BMG-
Labtech). The location of the quadrupole LSPR peak was detected by fitting a seventh 
order polynomial to the spectrum. The fitted spectrum resulted from averaging 200 
flashes per well at a 1 nm spectral resolution; the scanning rate for each well was less 
than 1 second. All experiments were performed at room temperature. 
The total amount of the CTB was calculated from the amount of CTB added. The 
amount of bound CTB was calculated from the observed LSPR shifts. The individual 
replicate LSPR shift was obtained by finding the wavelength corresponding to the 
maximum optical density given by the seventh order polynomial peak fitting. Then the 
12 
LSPR shifts of eight replicate wells were averaged to give the observed LSPR shift used 
to calculate the amount of bound CTB based on the Streptavidin-Biotin binding 
calibration. The difference between the total amount of CTB and the amount of bound 
CTB gave the amount of unbound CTB. 
2.2.8 Calibration of silica coated silver nanocubes 
2.2.8.1 Glycerol-Water test 
Sensitivity of the silica coated silver nanocubes was determined by varying the 
dielectric environment of the cubes by placing them in solvents of known refractive 
indices. Mixtures of glycerol water were prepared and the Ag@SiO2 cubes were 
suspended in them. The variation in the location of the localized surface plasmon 
resonance peak with change in refractive index was evaluated. (Figure 4) 
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Figure 4. Glycerol water test results to estimate the sensitivity of cubes 
2.2.8.2 Streptavidin-Biotin-DPPE calibration 
The binding of streptavidin with Biotin-DPPE is very strong and therefore, may 
be assumed to be irreversible. Lipids with 1% biotin are prepared and a supported lipid 
bilayer was coated on the Ag@SiO2 cubes. The binding with streptavidin allows the 
calibration of cubes by estimating the shifts in the localized surface plasmon peak as a 
function of protein density. (Figure 5) The surface density of streptavidin can be 
calculated by calculating the surface area of lipids assuming each lipid is DOPC. [11] 
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Figure 5. Streptavidin-Biotin-DPPE Calibration showing the variation of LSPR shift 
with surface density of Streptavidin [11] 
 
 
 
 
2.2.8.3 CTB binding calculation 
The amount of bound CTB is estimated by calculating shifts in the location of the 
LSPR peak and calculating protein density based on Streptavidin-Biotin calibration. The 
amount of unbound CTB is the difference between the total amount of CTB taken and 
the amount of bound CTB. 
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2.3 Cholera toxin 
To study the application of our technology, the model system of cholera toxin 
was studied. Cholera toxin has two subunits, five B subunits which are responsible for 
the interaction of the toxin with the cell membrane and an A subunit which imparts 
virulence to the toxin. (Figure 6) [21] The presence of five binding sites makes the 
binding of CTB multivalent allowing the illustration of importance of cooperativity in 
multivalent binding. 
It has been well-established in literature that cholera toxin binds with 
monosialoganglioside GM1 (GM1) found in the cell membrane of intestinal cells. [22] 
Once the B subunits bind with the GM1, the toxin gets endocytosed by the cell. The A 
subunit gets activated and stimulates the adenylate cyclase, increasing the production of 
cyclic AMP levels. This activates the cystic fibrosis transmembrane conductance 
regulator which causes a sudden efflux of ions and water from the cell resulting in rice 
water like stool. This severe diarrhea may result in the death of an infected individual. 
 16 
 
 
Figure 6. Schematic illustrating the structure of cholera toxin (The A subunit is shown in 
red while the B subunits are shown in blue) [23, 24]   
17 
3. CTB BINDING WITH GM1 
*
The most obvious choice to study the binding of cholera toxin was GM1 as the 
binding of CTB with GM1 has been studied numerous times. [25-31] Therefore, the 
binding of cholera toxin with different compositions of GM1 was studied. At a specific 
composition of lipid, the concentration of CTB was varied to obtain the equilibrium 
binding curve. 
A semi empirical Hill-Waud model was fit through this data to obtain the 
dissociation constant, cooperativity and binding capacity, which have been explained 
below: [30] 
Hill Waud model :  C=Cmax×
[P]n
Kh
n + [P]n
………………………………………………(1)
where, Cmax  is the binding capacity of the lipid bilayer, Kh is the apparent dissociation 
constant and n is the coefficient of cooperativity and are obtained by fitting experimental 
data with the above model. C is the concentration of the bound CTB while P is the 
concentration of the unbound CTB. P is obtained by subtracting the concentration of the 
bound CTB from total CTB added. The concentration of total CTB is predetermined 
while C is obtained through experiments. 
*Reprinted with permission from “Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera
Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” by Nolan C. Worstell, 
Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), Copyright [2016] by 
Worstell et al. [11] 
_______________________________
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An n value greater than 1 implies positive cooperativity while a value less than 1 
implies negative cooperativity. The physical significance of the n value is that it 
highlights whether one binding favors or hinders subsequent binding. If it favors further 
binding, it is greater than 1; else it is less than 1. 
Several different compositions of GM1 were taken including 1, 2, 4 and 10 
mol%. (Figure 7) On increasing the mol% of GM1 in the lipid bilayer, the binding 
capacity increased. The dissociation constant was also found to increase with increasing 
mol% of GM1. The n value in all cases was found to be greater than 1, indicating 
positive cooperativity. (Table 1) Therefore, as one GM1 binds, it favors further binding. 
These results match those obtained by Shi et al. [30] 
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Figure 7. Binding curves for CTB binding with GM1 (1, 2, 4 and 10 mol %) 
 
 
 
Table 1. Fitted parameters using Hill's Equation for 1, 2, 4 and 10 mol % GM1 
GM1 % Kh  (nM) Cmax (nM) n R
2
 
1 5.6 + 0.6 5.3 + 0.1 2.25 + 0.45 0.943 
2 14.5 + 1.0 11.5 + 0.3 1.93 + 0.25 0.968 
4 48.0 + 3.0 41.0 + 1.8 2.79 + 0.45 0.959 
10 151.0 + 7.0  79.0 +  2.3 2.79 +  0.31 0.986 
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4. CTB BINDING WITH LIGANDS OTHER THAN GM1 
*
Beyond GM1, other GM1-like gangliosides associated with CTB have been 
identified. Most of the previous studies identified GM1- and GM1-like ganglioside-CTB 
binding avidities with isothermal titration calorimetry (ITC), mass spectrometry (MS), or 
immobilized receptors on solid substrates. [26, 29, 32-35]  Some studies conducted the 
CTB-ganglioside binding measurements using fluidic lipid bilayers. [29, 31, 36-39] 
Regardless of measurement technique, these studies often reported the apparent 
association constants and thermodynamic parameters of CTB binding to various 
gangliosides, but few of them analyzed the cooperative actions between bound 
gangliosides. In the past, CTB has been used to quantify the amount of GM1 that was 
present in a cell membrane [40, 41] , but the validity of this approach was refuted by 
Yanagisawa et al. [42]  In the absence of GM1, Yanagisawa et al. observed strong 
reactivity between CTB and embryonic neuroepithelial cells and attributed this 
phenomenon to the expression of GM1- like ganglioside. To further investigate 
cooperative interaction in multivalent CTB binding to GM1-like gangliosides, two 
gangliosides, fucosyl-GM1 and GM2, were selected, which exhibit mild and weak 
binding avidity to CTB, respectively. At a specific composition of lipids in the bilayer (2 
mol %), the binding curves of three gangliosides, GM1, GM2 and fGM1 were compared. 
(Figure 8) 
*Reprinted with permission from “Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera
Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” by Nolan C. Worstell, 
Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), Copyright [2016] by 
Worstell et al. [11] 
_______________________________
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Figure 8. Binding curves for CTB binding with 2 mol % GM1, fGM1 and GM2 
 
 
The Hill-Waud model was also fit to the experimental data to estimate Kh , Cmax  
and n. (Table 2) Kh was found to be at least an order of magnitude higher for fGM1. In 
the case of GM2, it was not possible to estimate the Kh or Cmax with accuracy as it 
wasn’t possible to reach the plateau region of the binding curve, which lay beyond 
physiologically relevant concentrations of CTB.  
The n value could be determined for both cases and was found to be less than 1 
highlighting that their binding is negatively cooperative. One surprising observation was 
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that the Cmax value was greater for fGM1 than GM1 even though it has a lower binding 
avidity for CTB (illustrated by its higher Kh value).  
 
 
 
Table 2. Fitted parameters using Hill's Equation for 2 mol % GM1, fGM1 and GM2 
mol % of Lipid Hill's Equation fitting parameters 
GM
1
 
% 
fGM
1 
% 
GM
2 
% 
K
h
 (nM) C
max 
(nM) n R
2
 
0 2 0 251.8 + 47.1 83.5 + 5.3 0.89 + 0.10 0.985 
2 0 0 14.5 + 1.0 11.5 + 0.3 1.93 + 0.25 0.968 
0 0 2 (1.661 + n/a) ∙10
8*
 (6.39 + 2.91) ∙10
3*
 0.70 + 0.04 0.971
*
 
*The value ± S.E. of the estimate given is highly uncertain since plateau region was not reached 
 
 
 
The higher Cmax value may be explained through the change in cooperativity. 
Binding capacity increases for negatively cooperative ligands because negative 
cooperativity hinders subsequent binding. Therefore, for a given number of ligands, the 
number of CTB pentamers with which they bind is higher since fewer sites are occupied. 
In the case of positively cooperative ligands, more sites are occupied as subsequent 
binding is favored which implies they bind with fewer CTB pentamers. 
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To ensure that the degradation of GM1 did not cause unexpected lower binding 
capacity, the quality of GM1 was also verified by testing GM1 from three different 
vendors (Avanti, Matreya and Sigma). All three were found to be similar. (Figure 9) 
 
 
 
Figure 9. Binding curves for CTB binding with 2 mol % GM1 from three different 
vendors [11] 
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5. CTB BINDING WITH fGM1 
* 
Several different compositions of fGM1 were also studied to verify if it is 
negatively cooperative for different compositions. 
On obtaining binding curves for 0.5, 1, 1.5 and 2%, it could be observed that on 
increasing the mol% of fGM1, the binding capacity increased just like what was 
observed for GM1. (Figure 10) The Kh value was also found to increase with increasing 
mol% of fGM1. The n value in all cases was found to be either less than 1 or close to 1 
indicating negatively cooperative or non-cooperative binding. (Table 3) 
Table 3. Fitted parameters using Hill's Equation for fGM1 (0.5, 1, 1.5 and 2 mol %) 
Lipid composition (mol %) Hill's Equation fitting parameters
fGM
1 
% K
h
 (nM) C
max 
(nM) n R
2
0.5 59.4 + 5.7 12.0 + 0.3 0.78 + 0.05 0.993
1 270.8 + 56.8 32.5 + 1.9 0.69 + 0.06 0.992
1.5 129.1 + 13.0 34.4 + 1.1 1.06 + 0.09 0.989
2 251.8 + 47.1 83.5 + 5.3 0.89 + 0.10 0.985
*Reprinted with permission from “Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera
Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” by Nolan C. Worstell, 
Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), Copyright [2016] by 
Worstell et al. [11] 
_______________________________
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Figure 10. Binding curves for CTB binding with fGM1 (0.5, 1, 1.5 and 2 mol %) 
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6. CTB BINDING WITH MIXTURES OF fGM1 AND GM2 
*
Mixtures of fGM1 and GM2 were also studied to understand how one ligand can 
influence the binding of another (both are negatively cooperative ligands). Keeping the 
total ligand composition as 2 mol%, different amounts of fGM1 and GM2 were taken as 
follows: 0.5 mol% fGM1 + 1.5 mol% GM2, 0.75 mol% fGM1 + 1.25 mol% GM2, 1 
mol% fGM1 + 1 mol% GM2 and 1.5 mol% fGM1 + 0.5 mol% GM2. Binding curves were 
made for all cases and the Hill-Waud model was fit to the experimental data. (Table 4) 
As the Hill-Waud model assumes single receptor binding, the parameters obtained from 
the fitting lack physical significance for mixtures. 
Table 4. Fitted parameters using Hill's Equation for mixtures of fGM1 and GM2 
Lipid composition 
(mol %)
Hill's Equation fitting parameters
fGM
1 
% GM
2 
% K
h
 (nM) C
max 
(nM) n R
2
0.5 1.5 563.4 + 156.4 88.7 + 8.5 0.85 + 0.11 0.982
0.75 1.25 380.4 + 159.1 91.0 + 9.1 0.56 + 0.07 0.978
1 1 830.5 +114.6 96.6  +4.9 0.82 +0.04 0.998
1.5 0.5 682.7 + 190.5 92.6 + 7.9 0.69 + 0.05 0.993
*Reprinted with permission from “Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera
Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” by Nolan C. Worstell, 
Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), Copyright [2016] by 
Worstell et al. [11] 
_______________________________
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Surprisingly, at the highest concentration of free CTB tested (3.4 µM), amount of 
CTB bound was similar to 2 mol% fGM1. (Figure 11) This implied that GM2 was able to 
bind with CTB in the presence of fGM1 and compensated for the reduced concentration 
of fGM1. If the binding of fGM1 and GM2 were independent of each other, the binding 
capacity in each case would be different. However, this is not observed and highlights 
that heterogeneous mixtures of ligands may bind differently than if only pure 
components were present. This illustrates how weak binding ligands may have a 
significantly enhanced binding capacity in the presence of other stronger binding 
ligands. 
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Figure 11. Binding curves for CTB binding with mixtures of fGM1 and GM2 
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7. CTB BINDING WITH CONTROL 
*
A control of 90% DOPC and 10% DOPS was taken to ensure there is no non-
specific binding of CTB with the lipid bilayer. (Figure 12) There was negligible binding 
observed highlighting the absence of non-specific binding. 
Figure 12. Binding curves for CTB binding with control 
*Reprinted with permission from “Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera
Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” by Nolan C. Worstell, 
Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), Copyright [2016] by 
Worstell et al. [11] 
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8. THEORETICAL MODEL TO STUDY THE INFLUENCE OF COOPERATIVITY
ON BINDING CAPACITY 
*
To elucidate the surprisingly higher binding capacity observed for fGM1, a 
stepwise binding model was adapted from Klassen and his coworkers. (Figure 13) [43] 
They used direct electrospray ionization mass spectrometry to estimate binding constants 
for different states observed in their model. They considered the influence of either one 
or both adjacent sites being occupied by GM1 ligands and used three apparent binding 
constants to describe reaction paths to all possible states. 
Figure 13. Stepwise binding model adapted from Klassen and his coworkers  [11] [43] 
*Reprinted with permission from “Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera
Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array” by Nolan C. Worstell, 
Pratik Krishnan, Joshua D. Weatherston, Hung-Jen Wu, 2016,  PLoS ONE, 11(4), Copyright [2016] by 
Worstell et al. [11] 
_______________________________
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Writing the material balance for a CTB pentamer (P),  
𝐏𝐓 = [𝐏] + [𝐏𝐋] + [𝐏𝐋𝟐′] + [𝐏𝐋𝟐′′] + [𝐏𝐋𝟑′] + [𝐏𝐋𝟑′′] + [𝐏𝐋𝟒] + [𝐏𝐋𝟓]……………… (2) 
where PT is the total concentration of CTB, [P] is the concentration of free CTB, and 
[PL]/[PL2]/[PL3]/[PL4]/[PL5] are the protein-ligand binding complexes with 1, 2, 3, 4, 
and 5 ligands respectively 
Writing material balance for the ligand L,  
𝐋𝐓 = [𝐋] + [𝐏𝐋] + 𝟐 × ([𝐏𝐋𝟐′] + [𝐏𝐋𝟐′′]) + 𝟑 × ([𝐏𝐋𝟑′] + [𝐏𝐋𝟑′′]) + 𝟒 × [𝐏𝐋𝟒] + 𝟓 × 
[𝐏𝐋𝟓]…………………………………………………………………………………… (3)  
where LT is the total concentration of ligands and L is concentration of unbound ligands.  
At equilibrium, each reaction species have material balances as follows: 
 [𝐏𝐋] = 𝟓 × 𝐊𝟏[𝐏][𝐋]………………………………………………………………….. (4) 
 [𝐏𝐋𝟐′] = [𝐏𝐋][𝐋] = 𝟓 × 𝐊𝟏𝐊𝟐[𝐏][𝐋]
2
 ……………………………………..…………....(5) 
 [𝐏𝐋𝟑′] = [𝐏𝐋𝟐′][𝐋] = 𝟓 × 𝐊𝟏𝐊𝟐
2
[𝐏][𝐋]3……………………………………………...... (6) 
 [𝐏𝐋𝟒] = [𝐏𝐋𝟑′][𝐋] = 𝟓 × 𝐊𝟏𝐊𝟐
3
[𝐏][𝐋]4 ………………………………………...………(7) 
 [𝐏𝐋𝟓] = 𝐊𝟑
5
[𝐏𝐋𝟒][𝐋] = 𝐊𝟏𝐊𝟐
3𝐊𝟑[𝐏][𝐋]
5
 ……………………………………………….(8)  
[𝐏𝐋𝟐′′] = [𝐏𝐋][𝐋] = 𝟓 × 𝐊𝟏
2
[𝐏][𝐋]2 ………………………………………….…………(9) 
 [𝐏𝐋𝟑′′] = [𝐏𝐋𝟐′′][𝐋] = 𝟓 × 𝐊𝟏
2𝐊𝟐[𝐏][𝐋]
3……………………………………..……. ...(10)  
 
2 and 3 can be written as: 
 𝐏𝐓 = [𝐏] + 𝟓 × 𝐊𝟏[𝐏][𝐋] + 𝟓 × 𝐊𝟏𝐊𝟐[𝐏][𝐋]
2
 + 𝟓 × 𝐊𝟏
2
[𝐏][𝐋]2 + 𝟓 × 𝐊𝟏𝐊𝟐
2
[𝐏][𝐋]3 + 𝟓 
× 𝐊𝟏
2𝐊𝟐[𝐏][𝐋]
3
 + 𝟓 × 𝐊𝟏𝐊𝟐
3
[𝐏][𝐋]4 + 𝐊𝟏𝐊𝟐
3𝐊𝟑[𝐏][𝐋]
5
 ……………………………..(11)  
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𝐋𝐓 = 𝐋 + 𝟓 × 𝐊𝟏[𝐏][𝐋] + 𝟐 × (𝟓 × 𝐊𝟏𝐊𝟐[𝐏][𝐋]
2
 + 𝟓 × 𝐊𝟐
2
[𝐏][𝐋]2) + 𝟑 × (𝟓 × 
𝐊𝟏𝐊𝟐
2
[𝐏][𝐋]3 + 𝟓 × 𝐊𝟏
2𝐊𝟐[𝐏][𝐋]
3
 )+ 𝟒 × (𝟓 × 𝐊𝟏𝐊𝟐
3
[𝐏][𝐋]4 )+ 𝟓 × 𝐊𝟏𝐊𝟐
3𝐊𝟑[𝐏][𝐋]
5
 
…………………………………………………………………………………………(12) 
 
The values for K1, K2, and K3 for CTB binding with GM1 are 3.2 x 10
6
 M
-1
, 5.5 x 10
6
 M
-
1
, and 9.5 x 10
6
 M
-1
 respectively. Considering cooperative interactions, K2 and K3 are 
multiplied by a factor ‘α’. Therefore,  
𝑲𝟐 = 𝜶 × 𝑲𝟏………………………………………………………………………...…(13) 
𝑲𝟑 = 𝜶
2
× 𝑲𝟏 …………………………………………………………………………..(14)  
 
α is around 2 when GM1 is the binding receptor. α less than 1 implies negatively 
cooperative binding. Choosing an arbitrary α less than 1 (to represent fGM1 and GM2), 
we take α = 0.5. The value of LT was taken to be 1 µM and P was varied from 0.1 nM to 
1 µM. L was then estimated from (12). PT – P gives the amount of bound CTB. 
A plot of unbound vs. bound CTB for the two cases shows how the binding 
capacity is higher if the ligand is negatively cooperative. (Figure 14) The K1 value was 
also reduced to reflect the lowered avidity of fGM1 for CTB and the results were still 
consistent. This proved the experimental results were indeed correct. 
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Figure 14.  Simulated binding curves based on the stepwise binding model for CTB 
binding with GM1 and a negatively cooperative ligand (α =1/2) with same K1 and a 
lowered K1 
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Figure 15. Simulated binding curves based on the stepwise binding model for CTB 
binding with ligands by varying cooperativity at a fixed unbound CTB concentration 
(500 nM) 
 
 
 
Positive cooperativity favored higher binding states and limited the number of 
ligands available to bind to CTB resulting in a lower binding capacity as compared to 
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Thus, this theoretical model provided an understanding of how negatively 
cooperative ligands may exhibit higher binding capacity even though they may have 
lower avidity. 
36 
9. GLYCOARRAY TO STUDY HETEROGENEOUS BINDING COOPERATIVITY
It has been demonstrated that the weak binding ligand (GM2) was activated by 
strong binding ligand (fGM1) resulting in higher binding capacity. The binding of CTB 
with two different gangliosides, fGM1 and GM2 were investigated previously. Some 
researchers have claimed that CTB may bind with other GM1-like glycolipids, such as 
GD1b, aGM1 and possibly GM3. (Figure 16) [25, 27, 31] The positive binding 
cooperativity among these ligands may alter the CTB binding capacities on 
heterogeneous cell surfaces. 
Figure 16. Schematic highlighting the sugar groups in the relevant gangliosides [44] 
37 
To understand the influences of heterogeneous binding cooperativity, a 
glycoarray was constructed with these ligands and different combinations of these 
ligands were studied. (Table 5) This allowed the understanding of enhancement in 
binding for mixtures and the study of the influence of structures of gangliosides in 
binding with CTB. The gangliosides considered for this glycoarray include: GM1, GM2, 
fGM1, GD1b and GM3. 
Table 5. Glycoarray of several ligands 
GM1 GM2 GM3 fGM1 GD1b 
GM1 
GM2 
GM3 
fGM1 
GD1b 
The preliminary data obtained have been shown here. For pure components 1 
mol % was taken and the entire binding curve was obtained. (Figure 17) Binary mixtures 
were considered and each component had a composition of 1 mol %. For these, two 
points at higher CTB concentrations (706 nM and 1726 nM) were considered so as to 
illustrate how binding capacity varies for different ligand compositions. 
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Figure 17.  Pure component binding data for ligands used in the glycoarray 
To study enhancement in binding for mixtures, heterogeneous cooperativity was defined 
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39 
gangliosides are negatively cooperative. A concentration of 1% is chosen so as to 
minimize the effect of steric hindrance [45] [46] and to prevent a heterogeneous 
distribution of the gangliosides [30] [47]. 
It is clear from the results obtained that some mixtures exhibit cooperativity in 
binding. (Table 6 and Table 7) Some of the mixture pairs that seemed to exhibit 
significant positive cooperativity were: 
1. GM1 +GM2
2. fGM1+GM2
3. GD1b+GM2
4. GD1b+GM3
More statistical analysis into the data collected may highlight in which cases the 
cooperativity is significant. It is likely that fGM1+ GM3 also exhibits positive 
cooperative, but more experiments need to be conducted before that may be concluded. 
It should be noted that for GM2 and GM3, the binding was taken to be zero since no 
significant binding was observed in either case. Also, for the combination of GM2 and 
GM3, no significant binding was observed. Therefore, for this case cooperativity was 
taken as 1. 
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Table 6. CTB binding with different ligands at a total CTB concentration of 706 nM, 
green highlights positive cooperativity (>1.5) 
  GM1 fGM1 GD1b GM2 GM3 
GM1 1.0 1.1 0.9 1.5 1.2 
fGM1   1.0 0.9 1.6 1.2 
GD1b     1.0 2.3 2.1 
GM2       1.0 1.0 
GM3         1.0 
 
 
 
 
 
Table 7. CTB binding with different ligands at a total CTB concentration of 1726 nM, 
green highlights positive cooperativity (>1.5) 
  GM1 fGM1 GD1b GM2 GM3 
GM1 1.0 1.1 1.1 2.2 1.0 
fGM1   1.0 1.1 1.5 1.1 
GD1b     1.0 2.2 2.0 
GM2       1.0 1.0 
GM3         1.0 
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10. NO ENHANCEMENT OF BINDING IN MIXTURES OF OLIGOSACCHARIDE 
GM1 AND GLYCOLIPID GM2 
 
To verify the cause of binding enhancement, GM1 oligosaccharide (GM1os) 
sugar were purchased and pre-bound to CTB. Ag@SiO2 nanocubes were then coated 
with a lipid bilayer having 2% GM1 and 2% GM2.The binding capacity at a total CTB 
concentration of 706 nM was measured while varying the sugar concentration. In the 
case of 2% GM1, the binding capacity was found to decrease with increase in sugar 
concentration. This is because as more CTB binds to GM1os, the lesser number will bind 
with the lipid bilayer on the Ag@SiO2 nanocubes.  In the case of 2% GM2, negligible 
binding was observed. This allows us to hypothesize that it is probably not the allosteric 
effect causing an enhancement in binding. This is because if allosteric effects were 
involved, the pre-bound CTB (with GM1os) would have avidity for the nanocubes and 
exhibit higher binding, which was not the case. The enhancement may be explained by 
understanding the mechanism of binding. It is possible that when both GM1 and GM2 are 
present simultaneously in the bilayer, the CTB binds first to the GM1 for which it has a 
high avidity. Now that one site on the CTB is bound to GM1, the remaining bindings will 
be two dimensional rather than the conventional three dimensional binding. But a 
reduction in dimensionality increases the rate of binding and the effective concentration 
of the ligands.[48-50] The time for searching new ligands to bind with is significantly 
lowered. In two dimensions, the concentration of ligands depends on the surface area 
rather than volume and also gets significantly affected. Therefore, it can be hypothesized 
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that the higher effective concentration of GM2 allows it to contribute to the binding 
resulting in an enhanced binding capacity. 
 
 
 
 
 
Figure 18. Binding of CTB (prebound with GM1os) with 2% GM1 and 2% GM2 
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11.  FUTURE WORK 
 
11.1 Optimization tool for studying complex interactions 
 
Analyzing complex multivalent binding in heterogeneous mixtures of lipids 
necessitates the use of an advanced tool to effectively design and study experiments. The 
binding of biomolecules with heterogeneous mixtures of carbohydrates enables the 
identification of the optimum mixture composition that maximizes binding. This data 
may be used to identify possible treatments for diseases where the biomolecule or 
disease causing agent will bind to a drug covered with a bilayer of this optimum lipid 
composition rather than the cell membrane of human cells.  
For simplicity, two lipids, GM1 and GM2 were chosen to make several 
compositions of a heterogeneous mixture of lipids. The binding capacity at 706 nM of 
total CTB concentration was studied over three different days. The experiments were 
repeated thrice to minimize inter-day variability.  
A color map has also been made to illustrate the highly nonlinear behavior of 
binding capacity (Figure 19) and preliminary results obtained have been shown in Table 
8. A complex model for understanding this nonlinear behavior will enable the 
identification of optimum mixture compositions. 
 
 
 
 44 
 
 
Figure 19. A color map showing the variation in binding capacity for GM1 and GM2 
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Table 8. Preliminary data highlighting the nonlinearity in binding capacity for mixtures of GM1+GM2 system 
S No. %GM1 %GM2 Day 1 Day 2 Day 3 
Average 
Shift (nm) 
Standard 
Deviation 
%Error 
1 0.7 0.7 1.02 1.03 0.99 1.02 0.02 1.95 
2 1.7 1.8 2.47 2.24 2.70 2.47 0.23 9.24 
3 0.1 1.6 0.92 0.79 0.99 0.90 0.10 11.31 
4 1.5 1.2 2.22 2.24 2.09 2.18 0.08 3.73 
5 0.5 1.4 1.38 1.66 1.47 1.50 0.14 9.50 
6 1.1 0.3 1.54 1.83 1.50 1.62 0.18 11.14 
7 0.3 1 0.87 1.17 1.02 1.02 0.15 14.88 
8 1.3 0.6 1.70 1.82 1.96 1.83 0.13 7.11 
9 0.9 0 1.08 0.87 1.09 1.01 0.12 12.30 
10 2 0.2 2.11 2.12 2.09 2.11 0.02 0.79 
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12. CONCLUSION 
 
In conclusion, nanocube sensors were successfully used to quantify the binding 
of CTB with several gangliosides. Binding capacity of CTB was found to increase on 
increase the amount of gangliosides. Some gangliosides were found to be positively 
cooperative and others negatively/ non- cooperative. Cooperativity was found to play a 
role in determining binding capacity. Mixing different types of ligands gave fascinating 
results. Weakly binding gangliosides were found to significantly augment binding 
capacity of CTB in the presence of other strongly binding gangliosides. This 
demonstrated why protein binding cannot be used to correlate carbohydrate expression. 
A theoretical model was adapted to explain this interesting phenomenon observed while 
analyzing multivalent binding with different gangliosides.  
The reason such a study was possible was because of the availability of a high 
throughput tool like the nanocube sensor. This technology allowed multiple replications 
and testing at several different experimental conditions. This illustrates the importance 
of such a technology in studying the binding of biomolecules and its potential in 
discovering treatments for diseases. 
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